Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

XVIIth Banff Conference on Allograft Pathology: The Banff Workshop heart report on microvascular inflammatory burden in heart transplantation and the impact of molecular and noninvasive diagnostic tools.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Mixed-Methods Development and Validation of PRO/PREM Items for Patients Undergoing Colon Polyp Surveillance.

Journal of clinical gastroenterology·2026
Same author

Laboratory Workup of Amyloidosis.

Archives of pathology & laboratory medicine·2025
Same author

Ultrasound-guided fine-needle aspiration biopsy of parathyroid adenomas in patients undergoing parathyroidectomy does not lead to clinically significant fibrosis.

Gland surgery·2025
Same author

A Multicenter Study to Evaluate Diagnostic Accuracy by Pathologists Using the Aperio GT 450 DX in Local and Remote Viewing Stations.

Archives of pathology & laboratory medicine·2025
Same author

Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices.

American journal of clinical pathology·2024

Related Experiment Video

Updated: Jul 6, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Cardiovascular tumor-like conditions.

Dylan V Miller1, William D Edwards

  • 1Division of Anatomic Pathology, Department of Laboratory Medicineand Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. miller.dylan@mayo.edu

Seminars in Diagnostic Pathology
|March 21, 2008
PubMed
Summary

Nonneoplastic heart lesions, including growths and infections, can mimic tumors. These conditions pose risks such as heart failure and sudden death.

Area of Science:

  • Cardiovascular Pathology
  • Cardiac Oncology

Background:

  • Heart tumors can be neoplastic or nonneoplastic.
  • Nonneoplastic lesions are the focus, encompassing a range of conditions.
  • These lesions can present clinically similar to neoplastic tumors.

Purpose of the Study:

  • To detail nonneoplastic heart lesions.
  • To highlight their clinical significance.
  • To differentiate them from neoplastic tumors.

Main Methods:

  • Review of nonneoplastic cardiac lesions.
  • Classification of various types including hamartomas, heterotopias, cysts, and infections.
  • Analysis of clinical presentations and implications.

Main Results:

More Related Videos

Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research
07:26

Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Jul 6, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research
07:26

Establishing a Physiologic Human Vascularized Micro-Tumor Model for Cancer Research

Published on: September 15, 2023

  • Identified nonneoplastic lesions include hamartomas, heterotopias, cysts, age-related growths, reactive proliferations, thrombotic lesions, infections, and infestations.
  • These lesions can mimic neoplastic tumors.
  • Clinical manifestations include obstruction, arrhythmias, embolization, heart failure, and sudden death.

Conclusions:

  • Nonneoplastic heart lesions are clinically significant.
  • They require careful diagnosis to distinguish from neoplastic tumors.
  • Prompt recognition and management are crucial to prevent severe cardiac events.